Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-β protein
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ oligomers bind to synaptic sites3 and reduce the density of spines in organotypic hippocampal slice cultures4–6, dissociated cultured neurons7–9 and transgenic mouse models10–12.”
From Amyloid beta from axons and dendrites reduces local spine number and plasticity (2010) · cites this paper as [7]
In the citing paper
“Consistent with these structural abnormalities, neurons treated with Aβ or that overexpress APP show depressed glutamatergic transmission4,7,13–16.”
From Amyloid beta from axons and dendrites reduces local spine number and plasticity (2010) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Rapid Actin-Based Plasticity in Dendritic Spines
Fischer, M., Kaech, S., Knutti, D., & Matus, A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80467-5 · Cited by 905
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
Motter, R., Vigo‐Pelfrey, C., Kholodenko, D., Barbour, R., Johnson‐Wood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380413 · Cited by 701
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Bateman, R. J., Munsell, L. Y., Morris, J. C., Swarm, R., Yarasheski, K. E., & Holtzman, D. M. (2006) · Nature Medicine · doi:10.1038/nm1438 · Cited by 599
Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582
Research works printed but not linked: 29
- Baloyannis, 1992, The acoustic cortex in Alzheimer’s disease, Acta Otolaryngol. Suppl., 494, 1, 10.3109/00016489209137072 · DOI
- Bell, 2006, The amyloid pathology progresses in a neurotransmitter-specific manner, Neurobiol. Aging, 27, 1644, 10.1016/j.neurobiolaging.2005.09.034 · DOI
- Blanpied, 2004, Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease, Biol. Psychiatry, 55, 1121, 10.1016/j.biopsych.2003.10.006 · DOI · Paper page
- Calabrese, 2005, Essential role for the PKC target MARCKS in maintaining dendritic spine morphology, Neuron, 48, 77, 10.1016/j.neuron.2005.08.027 · DOI · Paper page
- Cleary, 2005, Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function, Nat. Neurosci., 8, 79, 10.1038/nn1372 · DOI · Paper page
- D’Andrea, 2006, Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer’s disease pyramidal neurons, Curr. Pharm. Des., 12, 677, 10.2174/138161206775474224 · DOI
- Davidsson, 1998, Neurochemical dissection of synaptic pathology in Alzheimer’s disease, Int. Psychogeriatr., 10, 11, 10.1017/S1041610298005110 · DOI · Paper page
- Deshpande, 2006, Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons, J. Neurosci., 26, 6011, 10.1523/JNEUROSCI.1189-06.2006 · DOI · Paper page
- Einstein, 1994, Dendritic pathology of granule cells in Alzheimer’s disease is unrelated to neuritic plaques, J. Neurosci., 14, 5077, 10.1523/JNEUROSCI.14-08-05077.1994 · DOI
- Hsieh, 2006, AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss, Neuron, 52, 831, 10.1016/j.neuron.2006.10.035 · DOI · Paper page
- Ishibashi, 2006, Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer’s disease brain, J. Neurosci. Res., 84, 632, 10.1002/jnr.20952 · DOI
- Kohrmann, 1999, Fast, convenient, and effective method to transiently transfect primary hippocampal neurons, J. Neurosci. Res., 58, 831, 10.1002/(SICI)1097-4547(19991215)58:6<831::AID-JNR10>3.0.CO;2-M · DOI
- Koo, 1994, Evidence that production and release of amyloid beta-protein involves the endocytic pathway, J. Biol. Chem., 269, 17386, 10.1016/S0021-9258(17)32449-3 · DOI · Paper page
- Levites, 2006, Anti-Abeta42-and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model, J. Clin. Invest., 116, 193, 10.1172/JCI25410 · DOI · Paper page
- Lleo, 2006, Current pharmacotherapy for Alzheimer’s disease, Annu. Rev. Med., 57, 513, 10.1146/annurev.med.57.121304.131442 · DOI · Paper page
- Masliah, 2000, The role of synaptic proteins in Alzheimer’s disease, Ann. N.Y. Acad. Sci., 924, 68, 10.1111/j.1749-6632.2000.tb05562.x · DOI
- Moolman, 2004, Dendrite and dendritic spine alterations in Alzheimer models, J. Neurocytol., 33, 377, 10.1023/B:NEUR.0000044197.83514.64 · DOI · Paper page
- Oddo, 2006, The role of nicotinic acetylcholine receptors in Alzheimer’s disease, J. Physiol. Paris, 99, 172, 10.1016/j.jphysparis.2005.12.080 · DOI
- Pitschke, 1998, Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer’s patients by fluorescence correlation spectroscopy, Nat. Med., 4, 832, 10.1038/nm0798-832 · DOI · Paper page
- Podlisny, 1995, Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture, J. Biol. Chem., 270, 9564, 10.1074/jbc.270.16.9564 · DOI · Paper page
- Probst, 1983, Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region, Brain Res., 268, 249, 10.1016/0006-8993(83)90490-0 · DOI · Paper page
- Rogawski, 2003, The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease, CNS Drug Rev., 9, 275, 10.1111/j.1527-3458.2003.tb00254.x · DOI · Paper page
- Selkoe, 2006, The ups and downs of Abeta, Nat. Med., 12, 758, 10.1038/nm0706-758 · DOI
- Shrestha, 2006, Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons, Mol. Cell Neurosci., 33, 274, 10.1016/j.mcn.2006.07.011 · DOI · Paper page
- Small, 2006, Alois Alzheimer and Alzheimer’s disease: a centennial perspective, J. Neurochem., 99, 708, 10.1111/j.1471-4159.2006.04212.x · DOI
- Sonkusare, 2005, Dementia of Alzheimer’s disease and other neurodegenerative disorders—memantine, a new hope, Pharmacol. Res., 51, 1, 10.1016/j.phrs.2004.05.005 · DOI · Paper page
- Townsend, 2006, Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers, J. Physiol., 572, 477, 10.1113/jphysiol.2005.103754 · DOI · Paper page
- Walsh, 2002, Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition, Biochem. Soc. Trans., 30, 552, 10.1042/bst0300552 · DOI · Paper page
- Ziv, 1996, Evidence for a role of dendritic filopodia in synaptogenesis and spine formation, Neuron, 17, 91, 10.1016/S0896-6273(00)80283-4 · DOI · Paper page
Cited by
Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876
Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
Irvine, G. B., El-Agnaf, O. M., Shankar, G. M., & Walsh, D. M. (2008) · Molecular Medicine · doi:10.2119/2007-00100.irvine · Cited by 550
Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
Morris, G. P., Clark, I. A., & Vissel, B. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0135-5 · Cited by 522
Alzheimer's disease: synaptic dysfunction and Aβ
Shankar, G. M., & Walsh, D. M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-48 · Cited by 486
Synapses and Alzheimer's Disease
Sheng, M., Sabatini, B. L., & Sudhof, T. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005777 · Cited by 436
“3) (Hsieh et al. 2006; Calabrese et al. 2007; Lacor et al. 2007; Shankar et al. 2007; Wei et al. 2010).”
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
the Synaptic Health Endpoints Working Group, Colom-Cadena, M., Spires-Jones, T., Zetterberg, H., Blennow, K., Caggiano, A., DeKosky, S. T., Fillit, H., Harrison, J. E., Schneider, L. S., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00588-4 · Cited by 328
Amyloid beta from axons and dendrites reduces local spine number and plasticity
Wei, W., Nguyen, L. N., Kessels, H. W., Hagiwara, H., Sisodia, S., & Malinow, R. (2010) · Nature Neuroscience · doi:10.1038/nn.2476 · Cited by 357
Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 357
Molecular mechanisms of dendrite stability
Koleske, A. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3486 · Cited by 351
Synaptic changes in Alzheimer’s disease and its models
Pozueta, J., Lefort, R., & Shelanski, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.050 · Cited by 307
Toxic fibrillar oligomers of amyloid-β have cross-β structure
Stroud, J. C., Liu, C., Teng, P. K., & Eisenberg, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203193109 · Cited by 303
Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease
Knobloch, M., & Mansuy, I. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8018-z · Cited by 296
“in miniature excitatory postsynaptic currents (mEPSCs) amplitude [61, 62, 64], in NMDA receptor and AMPA”
BackgroundBeta amyloid oligomers and fibrils stimulate differential activation of primary microglia
Sondag, C. M., Dhawan, G., & Combs, C. K. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-1 · Cited by 295
Villemagne, V. L., Pike, K. E., Darby, D., Maruff, P., Savage, G., Ng, S., Ackermann, U., Cowie, T. F., Currie, J., Chan, S. G., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.008 · Cited by 292
Substrate-targeting γ-secretase modulators
Kukar, T. L., Ladd, T. B., Bann, M. A., Fraering, P. C., Narlawar, R., Maharvi, G. M., Healy, B., Chapman, R., Welzel, A. T., Price, R. W., et al. (2008) · Nature · doi:10.1038/nature07055 · Cited by 280
Self-citationAmyloid precursor protein (APP) regulates synaptic structure and function
Tyan, S.-H., Shih, A. Y.-J., Walsh, J. J., Maruyama, H., Sarsoza, F., Ku, L., Eggert, S., Hof, P. R., Koo, E. H., & Dickstein, D. L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.009 · Cited by 191
“The hippocampal cultures were prepared at a density of 300 cells/mm2 on poly-L-lysinecoated coverslips and maintained in neurobasal medium with B-27 supplement (Calabrese et al., 2007).”
MethodSelf-citationIzzo, N. J., Staniszewski, A., To, L., Fa, M., Teich, A. F., Saeed, F., Wostein, H., Walko, T., Vaswani, A., Wardius, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111898 · Cited by 180
“We tested several compounds that have, been reported to block the effects of Abeta oligomers, including the sugar alcohol scyllo-inositol (AZD103), the nAChR antagonist hexamethonium bromide, and the NMDAR antagonists MK-801 and memantine [21,23,54]; only memantine was active, weakly blocking oligomer effects at very…”
BackgroundThe PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
Bhaskar, K., Miller, M., Chludzinski, A., Herrup, K., Zagorski, M., & Lamb, B. T. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-14 · Cited by 177
Perez-Cruz, C., Nolte, M. W., van Gaalen, M. M., Rustay, N. R., Termont, A., Tanghe, A., Kirchhoff, F., & Ebert, U. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6142-10.2011 · Cited by 172
New developments on the role of NMDA receptors in Alzheimer's disease
Malinow, R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.001 · Cited by 132
Tampellini, D., Rahman, N., Gallo, E. F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D. M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2292-09.2009 · Cited by 127
“In fact, it was recently reported that picomolar concentrations of A could enhance LTP and memory (Puzzo et al., 2008; Garcia-Osta and Alberini, 2009), although this is controversial (Calabrese et al., 2007).”
BackgroundIzzo, N. J., Yuede, C. M., LaBarbera, K. M., Limegrover, C. S., Rehak, C., Yurko, R., Waybright, L., Look, G., Rishton, G., Safferstein, H., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12302 · Cited by 95
Aβ oligomers inhibit synapse remodelling necessary for memory consolidation
Freir, D. B., Fedriani, R., Scully, D., Smith, I. M., Selkoe, D. J., Walsh, D. M., & Regan, C. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.001 · Cited by 85
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E. (2020) · Cells · doi:10.3390/cells9122655 · Cited by 73
Ribarič, S. (2023) · Biomedicines · doi:10.3390/biomedicines11020355 · Cited by 66
Naito, Y., Tanabe, Y., Lee, A. K., Hamel, E., & Takahashi, H. (2017) · Scientific Reports · doi:10.1038/srep42548 · Cited by 42
Signaling via the p75 neurotrophin receptor facilitates amyloid-β-induced dendritic spine pathology
Patnaik, A., Zagrebelsky, M., Korte, M., & Holz, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70153-4 · Cited by 40
Metadata
- Authors
- Calabrese, B., Shaked, G. M., Tabarean, I. V., Braga, J., Koo, E. H., & Halpain, S.
- Venue
- Molecular and Cellular Neuroscience
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 35
- Issue
- 2
- Pages
- 183-193
- ISSN
- 1044-7431
- Cited by
- 114
- References
- 18
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.